Bérengère Gobin, Marc Baud' Huin, François Lamoureux, Benjamin Ory, Céline Charrier, et al.. BYL719, a new α-specific PI3K inhibitor: Single administration and in combination with conventional chemotherapy for the treatment of osteosarcoma: BYL719 PI3Kalpha inhibitor: therapeutic value in osteosarcoma.
International Journal of Cancer, Wiley, 2015, 136 (4), pp.784 - 796.
⟨10.1002/ijc.29040⟩.
⟨inserm-01644799⟩